Table 2 Univariate analysis for survival of ovarian metastases from extragenital cancer
Patients % | Median OS (m) | 95% CI (m) | P value | |
|---|---|---|---|---|
Primary cancer site | ||||
Colon & Rectum | 49.0 | 8.8 | 6.5-11.2 | 0.036† |
Stomach | 40.8 | 7.4 | 6.3-8.4 | |
Breast | 8.2 | 41.0 | 2.0-85.0 | 0.000‡ |
Biliary Duct | 1.4 | 6.0 | ||
Liver | 0.7 | NR | ||
Timing of metastasis to ovary | ||||
Metachronous | 62.6 | 10.2 | 8.3-13.2 | 0.027 |
Synchronous | 37.4 | 8.1 | 6.7-9.4 | |
Combined with metastases outside ovaries | ||||
No | 72.8 | 10.2 | 8.1-12.4 | 0.001 |
Yes | 27.2 | 5.9 | 3.8-8.0 | |
Locally invasion | ||||
No | 70.7 | 13.7 | 6.4-21.0 | 0.007 |
Yes | 29.3 | 8.0 | 7.1-9.0 | |
Ascites | ||||
≥1000 mL | 26.5 | 6.0 | 8.2-11.7 | 0.005 |
<1000 mL | 73.5 | 9.9 | 3.5-8.5 | |